HLB bioStep Co.,Ltd. (KOSDAQ:278650)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,420.00
0.00 (0.00%)
At close: Sep 3, 2026

HLB bioStep Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
33,32341,15746,17468,79914,8736,158
Short-Term Investments
--686.981,57855,000-
Trading Asset Securities
1,6912,186--27,1914,235
Cash & Short-Term Investments
35,01443,34346,86170,37797,06410,393
Cash Growth
9.33%-7.51%-33.41%-27.49%833.97%-30.30%
Accounts Receivable
7,9137,5497,4833,7307,0097,788
Other Receivables
390451.021,035337.142,738662.43
Receivables
8,6658,3618,9004,46910,06510,153
Inventory
2,1641,4911,5111,5511,6502,920
Prepaid Expenses
164.3347.9132.68249133.9710.39
Other Current Assets
8,3387,3635,0732,767512.375,520
Total Current Assets
54,34460,60662,47879,413109,42628,996
Property, Plant & Equipment
39,20637,93652,09440,67839,62639,867
Long-Term Investments
42,35537,08637,68744,91612,81115,051
Goodwill
-1,5426,4901,0491,0491,253
Other Intangible Assets
4,1142,8843,485750.69811.65722.08
Long-Term Deferred Tax Assets
147.53147.533,1001,0962,1271,302
Other Long-Term Assets
5,12414,9042,2742,8416,3167,414
Total Assets
145,766155,575168,329171,714172,18794,626

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
-1,4711,9041,5732,0501,648
Accrued Expenses
583.09689.75675.07438.93533.51324.38
Short-Term Debt
24,75024,36328,64454,3161,6891,189
Current Portion of Long-Term Debt
3,7483,7483,7483,4483,2243,000
Current Portion of Leases
402.93365.58414.96367.28398.72841.66
Current Income Taxes Payable
0.867.723.1119.77352.861,444
Other Current Liabilities
13,13917,33210,8964,5184,5278,134
Total Current Liabilities
42,62447,97846,28564,68212,77516,582
Long-Term Debt
1,6151,7951,5692,01785,91110,690
Long-Term Leases
498.84493.15320.38487.93418.11583
Pension & Post-Retirement Benefits
1,8811,7801,541310.49126.46259.14
Other Long-Term Liabilities
2,5382,5921,800643.61753.88151.03
Total Liabilities
49,15754,63851,51568,14199,98428,265

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
8,7168,7018,6737,8637,053765.19
Additional Paid-In Capital
46,24985,99384,86160,10431,82729,661
Retained Earnings
39,9935,36423,26530,72731,36634,476
Treasury Stock
-5,241-5,201-7,332-1,422--
Comprehensive Income & Other
2,3371,4162,4074,31830.94-315.38
Total Common Equity
92,05596,272111,874101,59070,27864,587
Minority Interest
4,5544,6654,9401,9831,9251,774
Shareholders' Equity
96,609100,937116,814103,57372,20266,361
Total Liabilities & Equity
145,766155,575168,329171,714172,18794,626

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
31,01530,76534,69660,63791,64116,304
Net Cash (Debt)
3,99912,57812,1659,7405,424-5,911
Net Cash Growth
86.18%3.40%24.90%79.57%--
Net Cash Per Share
241.80743.97724.71634.81387.40-422.29
Filing Date Shares Outstanding
16.9417.1516.8415.6314.1113.77
Total Common Shares Outstanding
16.9417.1516.8415.6314.1113.77
Working Capital
11,72012,62816,19314,73196,65112,414
Book Value Per Share
5433.225612.006643.726501.774982.084689.29
Tangible Book Value
87,94191,846101,89999,79068,41762,612
Tangible Book Value Per Share
5190.405353.996051.336386.574850.154545.87
Land
-15,54127,57615,25315,25313,417
Buildings
-30,24630,98524,97424,28023,327
Construction In Progress
-7040989.4-511.28